1989
DOI: 10.1007/bf00274255
|View full text |Cite
|
Sign up to set email alerts
|

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus

Abstract: Considerable disagreement exists regarding the levels of immunoreactive glucose dependent insulinotropic polypeptide in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Glucose dependent insulinotropic polypeptide levels were therefore studied during oral glucose and mixed meal tolerance tests in normal subjects (n = 31) and newly presenting previously untreated patients with Type 2 diabetes mellitus (n = 68). The tests were performed in random order after overnight fasts and blood samples were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
43
1

Year Published

1992
1992
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(47 citation statements)
references
References 28 publications
3
43
1
Order By: Relevance
“…The observed discrepancies between the present results and those of the cited investigation (14) could be due to either the limited sample size of the previous study or the methodological differences in the incretin hormone assays. Our results do on the other hand accord with other authors, describing increased GIP (20) and decreased active GLP-1 levels in patients with overt T2DM (21). Similarly, increased total and intact GIP levels accompanied by increased C-peptide levels have been shown in subjects with impaired glucose tolerance (22).…”
Section: Discussionsupporting
confidence: 93%
“…The observed discrepancies between the present results and those of the cited investigation (14) could be due to either the limited sample size of the previous study or the methodological differences in the incretin hormone assays. Our results do on the other hand accord with other authors, describing increased GIP (20) and decreased active GLP-1 levels in patients with overt T2DM (21). Similarly, increased total and intact GIP levels accompanied by increased C-peptide levels have been shown in subjects with impaired glucose tolerance (22).…”
Section: Discussionsupporting
confidence: 93%
“…And in streptozotocin-induced diabetic rats, enhanced Gip gene expression and elevated serum levels induced chronic desensitisation of GIP receptor in vivo [2]. Finally, human diabetic and/or obese patients have increased plasma GIP levels after an oral load of glucose [45] and increased fasting responses to GIP [46,47]. Moreover, insulinotropic effects of GIP are lost in type 2 diabetes patients and their first-degree relatives [48,49], while GLP-1 response is conserved.…”
Section: Discussionmentioning
confidence: 99%
“…Studies that directly compared GLP-1 responses following oral glucose vs mixed meal are scarce and the available studies did not find an altered GLP-1 response after both interventions among diabetic patients (7). GIP responses were found to be reduced (8), increased (7,9), but mostly unchanged in patients with diabetes (10,11,12,13). Possible explanations for these inconclusive findings on incretin responses among diabetic patients may relate to the assay used, the test meal, participant characteristics and probably sample size.…”
Section: Introductionmentioning
confidence: 95%